Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease

Clinical trial NCT04736966 · COMPLETED

Trial details

NCT number: NCT04736966
Sponsor: University of California, San Diego
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alcoholic Liver Disease

Start date: 2021-03-03
Primary completion: 2024-03-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.